References
- Tawfik, G. M.; Dila, K. A. S.; Mohamed, M. Y. F.; Tam, D. N. H.; Kien, N. D.; Ahmed, A. M.; Huy, N. T. A Step by Step Guide for Conducting a Systematic Review and Meta-Analysis with Simulation Data. Trop. Med. Health 2019, 47, 1–9. DOI: 10.1186/s41182-019-0165-6.
- Khakh, B. S.; Burnstock, G. The Double Life of ATP. Sci. Am. 2009, 301, 84–92. DOI: 10.1038/scientificamerican1209-84.
- Bramer, W. M.; de Jonge, G. B.; Rethlefsen, M. L.; Mast, F.; Kleijnen, J. A Systematic Approach to Searching: An Efficient and Complete Method to Develop Literature Searches. J. Med. Libr. Assoc. 2018, 106, 531–541. DOI: 10.5195/jmla.2018.283.
- Junger, W. G. Immune Cell Regulation by Autocrine Purinergic signalling. Nat. Rev. Immunol. 2011, 11, 201–212. DOI: 10.1038/nri2938.
- Fredholm, B.; Verkhratsky, A. Purines - 80 years and very much alive. Acta Physiol. (Oxf) 2010, 199, 91–92. DOI: 10.1111/j.1748-1716.2010.02113.x.
- Eltzschig, H. K.; Sitkovsky, M. V.; Robson, S. C. Purinergic Signaling during Inflammation. N. Engl. J. Med. 2012, 367, 2322–2333. DOI: 10.1056/NEJMra1205750.
- Lazarowski, E. R. Vesicular and Conductive Mechanisms of Nucleotide Release. Purinergic Signal 2012, 8, 359–373. DOI: 10.1007/s11302-012-9304-9.
- Saboor, M.; Ayub, Q.; Samina, I. M. Platelet Receptors; an Instrumental of Platelet Physiology. Pak. J. Med. Sci. 2013, 29, 891. DOI: 10.12669/pjms.293.3497.
- Gendaszewska-Darmach, E.; Kucharska, M. Nucleotide Receptors as Targets in the Pharmacological Enhancement of Dermal Wound Healing. Purinergic Signal 2011, 7, 193–206. Doi DOI: 10.1007/s11302-011-9233-z.
- Kronlage, M.; Song, J.; Sorokin, L.; Isfort, K.; Schwerdtle, T.; Leipziger, J.; Robaye, B.; Conley, P. B.; Kim, H.-C.; Sargin, S.; et al. Autocrine Purinergic Receptor Signaling is Essential for Macrophage Chemotaxis. Sci. Signal. 2010, 3, ra55. DOI: 10.1126/scisignal.2000588.
- Kobayashi, T.; Kouzaki, H.; Kita, H. Human Eosinophils Recognize Endogenous Danger Signal Crystalline Uric Acid and Produce Proinflammatory Cytokines Mediated by Autocrine ATP. J. Immunol. 2010, 184, 6350–6358. DOI: 10.4049/jimmunol.0902673.
- Arman, M.; Payne, H.; Ponomaryov, T.; Brill, A. Role of Platelets in Inflammation. In Kerrigan SW and Moran N (Editors) IntechOpen 2015 ISBN 978-953-51-2208-1. The Non-Thrombotic Role of Platelets in Health and Disease, Nov 18, 2015; p. 37. DOI: 10.5772/60536.
- Ayata, C. K.; Ganal, S. C.; Hockenjos, B.; Willim, K.; Vieira, R. P.; Grimm, M.; Robaye, B.; Boeynaems, J. M.; Di Virgilio, F.; Pellegatti, P.; et al. Purinergic P2Y2 Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice with Acute Liver Injury. Gastroenterology 2012, 143, 1620–1629. DOI: 10.1053/j.gastro.2012.08.049.
- Chen, J.; Zhao, Y.; Liu, Y. The Role of Nucleotides and Purinergic Signaling in Apoptotic Cell Clearance - Implications for Chronic Inflammatory Diseases. Front. Immunol. 2014, 5, 656. DOI: 10.3389/fimmu.2014.00656.
- Lommatzsch, M.; Cicko, S.; Müller, T.; Lucattelli, M.; Bratke, K.; Stoll, P.; Grimm, M.; Dürk, T.; Zissel, G.; Ferrari, D.; et al. Extracellular Adenosine Triphosphate and Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2010, 181, 928–934. DOI: 10.3389/fimmu.2014.00656.
- Klaver, D.; Thurnher, M. Control of Macrophage Inflammation by P2Y Purinergic Receptors. Cells 2021, 10, 1098. DOI: 10.3390/cells10051098.
- Cicko, S.; Lucattelli, M.; Müller, T.; Lommatzsch, M.; De Cunto, G.; Cardini, S.; Sundas, W.; Grimm, M.; Zeiser, R.; Dürk, T.; et al. Purinergic Receptor Inhibition Prevents the Development of Smoke-Induced Lung Injury and Emphysema. J. Immunol. 2010, 185, 688–697. DOI: 10.4049/jimmunol.0904042.
- Müller, T.; Robaye, B.; Vieira, R. P.; Ferrari, D.; Grimm, M.; Jakob, T.; Martin, S. F.; Di Virgilio, F.; Boeynaems, J. M.; Virchow, J. C.; Idzko, M. The Purinergic Receptor P2Y2 Receptor Mediates Chemotaxis of Dendritic Cells and Eosinophils in Allergic Lung Inflammation. Allergy 2010, 65, 1545–1553. DOI: 10.1111/j.1398-9995.2010.02426.x.
- Mai, Y.; Guo, Z.; Yin, W.; Zhong, N.; Dicpinigaitis, P. V.; Chen, R. P2X Receptors: Potential Therapeutic Targets for Symptoms Associated with Lung Cancer—A Mini Review. Front. Oncol. 2021, 11, 2412. DOI: 10.3389/fonc.2021.691956.
- Kouzaki, H.; Iijima, K.; Kobayashi, T.; O’Grady, S. M.; Kita, H. The Danger Signal, Extracellular ATP, is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses. J. Immunol. 2011, 186, 4375–4387. DOI: 10.4049/jimmunol.1003020.
- Riegel, A. K.; Faigle, M.; Zug, S.; Rosenberger, P.; Robaye, B.; Boeynaems, J. M.; Idzko, M.; Eltzschig, H. K. Selective Induction of Endothelial P2Y6 Nucleotide Receptor Promotes Vascular Inflammation. Blood J. Am. Soc. Hematol. 2011, 117, 2548–2555. DOI: 10.1182/blood-2010-10-313957.
- Zhang, Z.; Wang, Z.; Ren, H.; Yue, M.; Huang, K.; Gu, H.; Liu, M.; Du, B.; Qian, M. P2Y(6) agonist Uridine 5’-Diphosphate Promotes Host Defense against Bacterial Infection Via Monocyte Chemoattractant Protein-1-Mediated Monocytes/Macrophages Recruitment. J. Immunol. 2011, 186, 5376–5387. DOI: 10.4049/jimmunol.1002946.
- Spari, D.; Beldi, G. Extracellular ATP as an Inter-Kingdom Signaling Molecule: Release Mechanisms by Bacteria and Its Implication on the Host. Int. J. Mol. Sci. 2020, 21, 5590. DOI: 10.3390/ijms21155590.
- Di Virgilio, F.; Sarti, A. C.; Grassi, F. Modulation of Innate and Adaptive Immunity by P2X Ion Channels. Curr. Opin. Immunol. 2018, 52, 51–59. DOI: 10.1016/j.coi.2018.03.026.
- Dou, L.; Chen, Y. F.; Cowan, P. J.; Chen, X. P. Extracellular ATP Signaling and Clinical Relevance. Clin. Immunol. 2018, 188, 67–73. DOI: 10.1016/j.clim.2017.12.006.
- Kepp, O.; Bezu, L.; Yamazaki, T.; Di Virgilio, F.; Smyth, M. J.; Kroemer, G.; Galluzzi, L. ATP and Cancer Immunosurveillance. Embo J. 2021, 40, e108130. DOI: 10.15252/embj.2021108130.
- Di Virgilio, F.; Sarti, A. C.; Falzoni, S.; De Marchi, E.; Adinolfi, E. Extracellular ATP and P2 Purinergic Signalling in the Tumour Microenvironment. Nat. Rev. Cancer 2018, 18, 601–618. DOI: 10.1038/s41568-018-0037-0.
- Di Virgilio, F.; Dal Ben, D.; Sarti, A. C.; Giuliani, A. L.; Falzoni, S. The P2X7 Receptor in Infection and Inflammation. Immunity 2017, 47, 15–31. DOI: 10.1016/j.immuni.2017.06.020.
- Haas, C. B.; Lovászi, M.; Braganhol, E.; Pacher, P.; Haskó, G. Ectonucleotidases in Inflammation, Immunity, and Cancer. J. Immunol. 2021, 206, 1983–1990. DOI: 10.4049/jimmunol.2001342.
- Giuliani, A. L.; Sarti, A. C.; Di Virgilio, F. Ectonucleotidases in Acute and Chronic Inflammation. Front. Pharmacol. 2020, 11, 619458. DOI: 10.3389/fphar.2020.619458.
- Surprenant, A.; North, R. A. Signaling at Purinergic P2X Receptors. Annu. Rev. Physiol. 2009, 71, 333–359. DOI: 10.1146/annurev.physiol.70.113006.100630.
- Pelegrin, P.; Surprenant, A. P2RX7 (purinergic receptor P2X, ligand-gated ion channel, 7). Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2008. http://hdl.handle.net/2042/38574.
- Menzel, S.; Schwarz, N.; Haag, F.; Koch-Nolte, F. Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity. Front. Pharmacol. 2018, 9, 266. DOI: 10.3389/fphar.2018.00266.
- Savio, L. E.; de Andrade Mello, P.; Santos, S. A.; de Sousa, J. C.; Oliveira, S. D.; Minshall, R. D.; Kurtenbach, E.; Wu, Y.; Longhi, M. S.; Robson, S. C.; Coutinho-Silva, R. P2X7 Receptor Activation Increases Expression of Caveolin-1 and Formation of Macrophage Lipid Rafts, Thereby Boosting CD39 Activity. J. Cell Sci. 2020, 133, jcs237560. DOI: 10.1242/jcs.237560.
- Jacobson, K. A.; Müller, C. E. Medicinal Chemistry of Adenosine, P2Y and P2X Receptors. Neuropharmacology 2016, 104, 31–49. DOI: 10.1016/j.neuropharm.2015.12.001.
- Puchałowicz, K.; Tarnowski, M.; Baranowska-Bosiacka, I.; Chlubek, D.; Dziedziejko, V. P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System. Int. J. Mol. Sci. 2014, 15, 23672–23704. DOI: 10.3390/ijms151223672.
- Grbic, D. M.; Degagné, É.; Larrivée, J. F.; Bilodeau, M. S.; Vinette, V.; Arguin, G.; Stankova, J.; Gendron, F. P. P2Y6 Receptor Contributes to Neutrophil Recruitment to Inflamed Intestinal Mucosa by Increasing CXC Chemokine Ligand 8 Expression in an AP-1-Dependent Manner in Epithelial Cells. Inflammatory Bowel Dis. 2012, 18, 1456–1469. DOI: 10.1002/ibd.21931.
- Guns, P.-J. D. F.; Hendrickx, J.; Van Assche, T.; Fransen, P.; Bult, H. P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice. Br. J. Pharmacol. 2010, 159, 326–336. . DOI: 10.1111/j.1476-5381.2009.00497.x.
- Semple, J. W.; Italiano, J. E., Jr.; Freedman, J. Platelets and the Immune Continuum. Nat. Rev. Immunol. 2011, 11, 264–274. DOI: 10.1038/nri2956.
- Muhlestein, J. B. Effect of Antiplatelet Therapy on Inflammatory Markers in Atherothrombotic Patients. Thromb. Haemost. 2010, 103, 71–82. DOI: 10.1160/TH09-03-0177.
- Neves, J. S.; Radke, A. L.; Weller, P. F. Cysteinyl Leukotrienes Acting via Granule Membrane-Expressed Receptors Elicit Secretion from within Cell-Free Human Eosinophil Granules. J. Allergy Clin. Immunol. 2010, 125, 477–482. DOI: 10.1016/j.jaci.2009.11.029.
- Addi, A. B.; Cammarata, D.; Conley, P. B.; Boeynaems, J. M.; Robaye, B. Role of the P2Y12 Receptor in the Modulation of Murine Dendritic Cell Function by ADP. J. Immunol. 2010, 185, 5900–5906. Nov 15. DOI: 10.4049/jimmunol.0901799.
- Bunyavanich, S.; Boyce, J. A.; Raby, B. A.; Weiss, S. T. Gene-by-environment effect of house dust mite on purinergic receptor P2Y12 (P2RY12) and lung function in children with asthma. Clin. Exp. Allergy 2012, 42, 229–237. DOI: 10.1111/j.1365-2222.2011.03874.x.
- Khakh, B. S.; North, R. A. Neuromodulation by Extracellular ATP and P2X Receptors in the CNS. Neuron 2012, 76, 51–69. DOI: 10.1016/j.neuron.2012.09.024.
- Ledderose, C.; Bao, Y.; Kondo, Y.; Fakhari, M.; Slubowski, C.; Zhang, J.; Junger, W. G. Purinergic Signaling and the Immune Response in Sepsis: A Review. Clin. Ther. 2016, 38, 1054–1065. DOI: 10.1016/j.clinthera.2016.04.002.
- North, R. A.; Jarvis, M. F. P2X Receptors as Drug Targets. Mol. Pharmacol. 2013, 83, 759–769. DOI: 10.1124/mol.112.083758.
- Nemeth, E.; Ganz, T. Anemia of Inflammation. Hematol. Oncol. Clin. North Am. 2014, 28, 671–681. DOI: 10.1016/j.hoc.2014.04.005.
- Vieira, R. P.; Müller, T.; Grimm, M.; von Gernler, V.; Vetter, B.; Dürk, T.; Cicko, S.; Ayata, C. K.; Sorichter, S.; Robaye, B.; et al. Purinergic Receptor Type 6 Contributes to Airway Inflammation and Remodeling in Experimental Allergic Airway Inflammation. Am. J. Respir. Crit. Care Med. 2011, 184, 215–223. DOI: 10.1164/rccm.201011-1762OC.
- Asaduzzaman, M.; Lavasani, S.; Rahman, M.; Zhang, S.; Braun, O. Ö.; Jeppsson, B.; Thorlacius, H. Platelets Support Pulmonary Recruitment of Neutrophils in Abdominal Sepsis. Crit. Care Med. 2009, 37, 1389–1396. DOI: 10.1097/CCM.0b013e31819ceb71.
- Killeen, M. E.; Ferris, L.; Kupetsky, E. A.; Falo, L.; Mathers, A. R. Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of Psoriasis. J. Immunol. 2013, 190, 4324–4336. DOI: 10.4049/jimmunol.1202045.
- Kurashima, Y.; Amiya, T.; Nochi, T. Extracellular ATP Mediates Mast Cell-Dependent Intestinal Inflammation through P2X7 Purinoceptors. Nature Commun. 2012, 3, 1034. DOI: 10.1038/ncomms2023.
- Idzko, M.; Ferrari, D.; Eltzschi, H. Nucleotide signalling during inflammation. Nature 2014, 509, 310–317. DOI: 10.1038/nature13085.
- Larsen, S. T.; Jackson, P.; Poulsen, S. S.; Levin, M.; Jensen, K. A.; Wallin, H.; Nielsen, G. D.; Koponen, I. K. Airway Irritation, Inflammation, and Toxicity in Mice following Inhalation of Metal Oxide Nanoparticles. Nanotoxicology 2016, 10, 1254–1262. DOI: 10.1080/17435390.2016.1202350.
- Baek, A.; Kim, M.; Kim, S. H.; Cho, S. R.; Kim, H. J. Anti-Inflammatory Effect of DNA Polymeric Molecules in a Cell Model of Osteoarthritis. Inflammation 2018, 41, 677–688. DOI: 10.1007/s10753-017-0722-2.
- von Brühl, M.-L.; Stark, K.; Steinhart, A.; Chandraratne, S.; Konrad, I.; Lorenz, M.; Khandoga, A.; Tirniceriu, A.; Coletti, R.; Köllnberger, M.; et al. Monocytes, Neutrophils, and Platelets Cooperate to Initiate and Propagate Venous Thrombosis in Mice in Vivo. J. Exp. Med. 2012, 209, 819–835. DOI: 10.1084/jem.20112322.
- Hechler, B.; Gachet, C. Purinergic Receptors in Thrombosis and Inflammation. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 2307–2315. DOI: 10.1161/ATVBAHA.115.303395.
- Caudrillier, A.; R Looney, M. Platelet-Neutrophil Interactions as a Target for Prevention and Treatment of Transfusion-Related Acute Lung Injury. Curr. Pharm. Des. 2012, 18, 3260–3266. Jul 1https://www.ingentaconnect.com/content/ben/cpd/2012/00000018/00000022/art00017. DOI: 10.2174/1381612811209023260.
- Maugeri, N.; Campana, L.; Gavina, M.; Covino, C.; De Metrio, M.; Panciroli, C.; Maiuri, L.; Maseri, A.; D’Angelo, A.; Bianchi, M. E.; et al. Activated Platelets Present High Mobility Group Box 1 to Neutrophils, Inducing Autophagy and Promoting the Extrusion of Neutrophil Extracellular Traps. J. Thromb. Haemost. 2014, 12, 2074–2088. Dec. DOI: 10.1111/jth.12710.
- Totani, L.; Dell’Elba, G.; Martelli, N.; Di Santo, A.; Piccoli, A.; Amore, C.; Evangelista, V. Prasugrel Inhibits Platelet-Leukocyte Interaction and Reduces Inflammatory Markers in a Model of Endotoxic Shock in the Mouse. Thromb. Haemost. 2012, 107, 1130–1140. JunDOI: 10.1160/TH11-12-0867.
- Cox, D.; Kerrigan, S. W.; Watson, S. P. Platelets and the Innate Immune System: Mechanisms of bacterial-induced platelet activation . J. Thromb. Haemost. 2011, 9, 1097–1107. Jun. DOI: 10.1111/j.1538-7836.2011.04264.x.
- de Stoppelaar, S. F.; van ‘t Veer, C.; Claushuis, T. A. M.; Albersen, B. J. A.; Roelofs, J. J. T. H.; van der Poll, T. Thrombocytopenia Impairs Host Defense in Gram-Negative Pneumonia–Derived Sepsis in Mice. Blood J. Am. Soc. Hematol. 2014, 124, 3781–3790. Dec 11. DOI: 10.1182/blood-2014-05-573915.
- Bounes, F. V.; Mémier, V.; Marcaud, M.; Jacquemin, A.; Hamzeh-Cognasse, H.; Garcia, C.; Series, J.; Sié, P.; Minville, V.; Gratacap, M. P.; Payrastre, B. Platelet Activation and Prothrombotic Properties in a Mouse Model of Peritoneal Sepsis. Sci. Rep. 2018, 8, 1–2. DOI: 10.1038/s41598-018-31910-8.
- Pelegrín, P. P2X7 Receptor and the NLRP3 Inflammasome: Partners in Crime. Biochem. Pharmacol. 2020, 187, 114385. DOI: 10.1016/j.bcp.2020.114385.